Longevity Pulse
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
TutorialsClinical TutorialsVideosContinuous Listen
Free Subscription
Sign In
Deep Dive Audio
Short-Term Antipsychotic Use Raises Diabetes Risk in Young PeopleLongevity & Aging

Short-Term Antipsychotic Use Raises Diabetes Risk in Young People

A large Dutch cohort study found that antipsychotic medications raise the risk of type 2 diabetes in young people — even after just one year of use. Among nearly 90,000 youths, the relative risk of developing pharmacologically treated type 2 diabetes rose from near baseline at the start to more than three times higher by year five. Crucially, even those who only used antipsychotics in the first year still showed elevated diabetes risk afterward, suggesting the drugs trigger lasting metabolic changes. Antipsychotics are widely prescribed off-label to young people for conditions like ADHD, anxiety, and sleep disturbances — uses that experts say deserve much greater scrutiny given these findings.

0:00--:--
Read Full Article
Longevity Pulse

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Pulse. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Pulse is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.